The role of tumor size and patient's age as prognostic factors in laryngeal cancer

Hippokratia

Volumn 15, Issue 1, 2011, Pages 75-80

  Markou, K ^a   Goudakos, J ^a   Triaridis, S ^a   Konstantinidis, J ^a   Vital, V ^a   Nikolaou, A ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Carcinoma; Laryngeal; Recurrence; Size; Tumor

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECURRENCE RISK; TUMOR VOLUME;

EID: 79251481874     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. American Cancer Society. Cancer facts & figures 2007.
2. Myers EN, Smith MR, Myers J, Hanna E. Cancer of the Head and Neck. Philadelphia: Saunders, 2003.
3. Danic D, Maruic M, Uzarevic B, Milicic D. Prognostic factors in squamous cell carcinoma of the larynx. ORL J Otorhinolaryngol Relat Spec 2000; 62:143-148.
4. Eiband JD, Elias EG, Suter CM, Gray WC, Didolkar MS. Prognostic factors in squamous cell carcinoma of the larynx. Am J Surg 1989;158:314-317.
5. Spector JG, Sessions DG, Haughey BH. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. La- ryngoscope 2001;111:1079-1087.
6. Stankiewicz C. Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 1994;251:418-422.
7. American Joint Committee on Cancer (AJCC). Manual for staging of cancer. Philadelphia: JB Lippincott, 1997:p. 127-137.
8. International Union Against Cancer. TNM classification of ma- lignant tumours. New York: Wiley-Liss, 1997:p. 93-100.
9. Lukits J, Timar J, Juhasz A, Dome B, Paku S, Repassy G. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization. Otolaryngol Head Neck Surg 2001;125:18-22.
10. Gallo O, Sarno A, Baroncelli R, Bruschini L, Boddi V. Multivariate analysis of prognostic factors in T3 N0 laryngeal carcinoma treated with total laryngectomy. Otolaryngol Head Neck Surg 2003;128:654-662.
11. Pulkkinen JO, Klemi P, Martikainen P, Grenman R. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res 1999; 19:703-707.
12. Jin YT, Kayser S, Kemp BL. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squa- mous cell carcinoma. Cancer 1998; 82:2159-2165.
13. Gavilan J, Gavilan C, Manos-Pujol M, Herranz J. Discriminant analysis in predicting survival of patients with cancer of the larynx or hypopharynx. Clin Otolaryngol Allied Sci 1987;12:331- 335.
14. Stell PM. Prognosis in laryngeal carcinoma: host factors. Clin Otolaryngol Allied Sci 1990;15:111-119.
15. Manni JJ, Terhaard CH, de Boer MF. Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg 1992;164:682-687.
16. Kowalski LP, Franco EL, de Andrade Sobrinho J, Oliveira BV, Pontes PL. Prognostic factors in laryngeal cancer patients sub- mitted to surgical treatment. J Surg Oncol 1991;48:87-95.
17. Morales-Angulo C, Val-Bernal F, Buelta L, Fernandez F, Garcia-Castrillo L, Rama J. Prognostic factors in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 1998;119:548-553.
18. Barra S, Barzan L, Maione A. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 1994;104:95-98.